Drugs / NVXT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02343627 | Dec 2014 → Jan 2016 | tinea unguium | Sun Pharmaceutical Industries, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVXT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02343627 ↗ |
| Route | Topical | “NVXT Solution, applied to infected toe nails and 0.5 mm of adjacent skin once daily for 60 days.” NCT02343627 ↗ |